2020
A human secretome library screen reveals a role for Peptidoglycan Recognition Protein 1 in Lyme borreliosis
Gupta A, Arora G, Rosen CE, Kloos Z, Cao Y, Cerny J, Sajid A, Hoornstra D, Golovchenko M, Rudenko N, Munderloh U, Hovius JW, Booth CJ, Jacobs-Wagner C, Palm NW, Ring AM, Fikrig E. A human secretome library screen reveals a role for Peptidoglycan Recognition Protein 1 in Lyme borreliosis. PLOS Pathogens 2020, 16: e1009030. PMID: 33175909, PMCID: PMC7657531, DOI: 10.1371/journal.ppat.1009030.Peer-Reviewed Original ResearchConceptsPeptidoglycan recognition protein 1B. burgdorferi infectionB. burgdorferiBurgdorferi infectionHost responseLow serum IgG levelsCommon vector-borne illnessDiverse host responsesSerum IgG levelsProtein 1Vector-borne illnessImmune dysregulationIgG levelsBorreliacidal activityBurgdorferi sensu latoHuman extracellular proteinsSpirochete burdenTick biteB. burgdorferi sensu latoSpirochete Borrelia burgdorferiNervous systemLyme borreliosisLyme diseaseInfectionBorrelia burgdorferiChallenges in the Diagnosis and Treatment of Lyme Disease
Schoen R. Challenges in the Diagnosis and Treatment of Lyme Disease. Current Rheumatology Reports 2020, 22: 3. PMID: 31912251, DOI: 10.1007/s11926-019-0857-2.Peer-Reviewed Original ResearchConceptsTreatment of Lyme diseaseClinical featuresCourse of oral antibiotic therapyOral antibiotic therapyLate-stage manifestationLate-stage diseaseLyme diseaseAntibiotic therapyCausative organismTreatment strategiesClinical expressionLyme arthritisImpact of Lyme diseaseDiagnosisDiseasePatientsTreatmentVector-borne illnessStrains of Borrelia burgdorferiLymeWell-characterizedMorbidityTherapyFindingsIt
2015
Update on persistent symptoms associated with Lyme disease
Oliveira CR, Shapiro ED. Update on persistent symptoms associated with Lyme disease. Current Opinion In Pediatrics 2015, 27: 100-104. PMID: 25490690, PMCID: PMC4417349, DOI: 10.1097/mop.0000000000000167.Commentaries, Editorials and LettersConceptsViable B. burgdorferiLyme diseasePersistent symptomsB. burgdorferiConventional treatmentAntimicrobial treatmentCommon vector-borne illnessPersistent active infectionPersistent nonspecific symptomsVector-borne illnessConventional antimicrobial treatmentPersistent arthritisChronic symptomsNonspecific symptomsOngoing symptomsErythema migransActive infectionPersistent infectionRecent studiesSlow clearancePatientsSymptomsDiseaseNonviable organismsInfection
1999
Successful vaccination for Lyme disease:a novel mechanism
Thanassi W, Schoen R. Successful vaccination for Lyme disease:a novel mechanism. Expert Opinion On Investigational Drugs 1999, 8: 29-35. PMID: 15992056, DOI: 10.1517/13543784.8.1.29.Peer-Reviewed Original Research
1993
Protective immunity in lyme borreliosis
Fikrig E, Kantor FS, Barthold SW, Flavell RA. Protective immunity in lyme borreliosis. Trends In Parasitology 1993, 9: 129-131. PMID: 15463734, DOI: 10.1016/0169-4758(93)90176-g.Peer-Reviewed Original ResearchLyme diseaseCommon vector-borne illnessLyme borreliosisVector-borne illnessInitial diagnosisProtective immunityLate diseaseMurine modelSpirochete Borrelia burgdorferiVaccine candidatesSurface antigenEarly infectionDiseaseBorrelia burgdorferiBorreliosisTherapyVaccineIllnessInfectionAntigenDiagnosisImmunity
This site is protected by hCaptcha and its Privacy Policy and Terms of Service apply